期刊文献+

改进的HPLC法检查头孢呋辛钠中有关物质 被引量:2

Determination of Related Substances of Cefuroxime Sodium by an Improved HPLC Method
下载PDF
导出
摘要 目的:改进用于头孢呋辛钠中有关物质检查的HPLC法。方法:色谱柱为Agilent HC-C8(250 mm×4.6mm,5μm),以醋酸盐缓冲液(取醋酸钠0.68 g和冰醋酸5.8 g,加水稀释成1 000 mL的溶液,用冰醋酸调节pH值至3.4)为流动相A,乙腈为流动相B,线性梯度洗脱,流速为1.5 mL.min-1;检测波长为273 nm;进样量为20μL。结果:头孢呋辛与相邻杂质可基线分离,其在9.950~637.1 mg.L-1的范围内线性关系良好(r=0.999 9),检测限和定量限分别为0.08和0.2 mg.L-1;方法重复性良好,所测单个最大杂质含量的RSD为1.8%(n=6),总杂质含量的RSD为1.5%(n=6);方法耐用性好,适用于不同品牌的辛烷基键合硅胶色谱柱。结论:该方法专属、准确、灵敏,优于2005年版中国药典方法。 Objective :To improve the HPLC method for the determination of related substances of cefuroxime sodium.Methods:Agilent HC-C8,a column packed with octylsilane bonded silica gel,and acetate buffer(0.68 g sodium acetate and 5.8 g glacial acetic acid were diluted with water to 1000 mL and adjusted to pH 3.4 with glacial acetic acid) as the mobile phase A and acetontrile as mobile phase B at a flow rate of 1.5 mL ·min^-1 were used with a detection wavelength of 273 nm and an injection volume of 20 μL by linear gradient elution.Results:A good resolution of the peaks of cefuroxime and adjacent impurities was obtained.The linear range was 9.950-637.1 mg ·L-1(r=0.9999) for cefuroxime sodium.The limits of detection and quantitation for cefuroxime sodium were 0.008 and 0.2 mg ·L^-1,respectively.The method had a good reproducibility with a RSD of 1.8%(n=6) for the content of the maximum individual impurity and a RSD of 1.5%(n=6) for the total content of all impurities and showed a good ruggedness for variation of type of octylsilane columns.Conclusion:The method is specific,accurate,sensitive and superior to that in ChP2005.
出处 《药学进展》 CAS 2010年第10期468-471,共4页 Progress in Pharmaceutical Sciences
关键词 头孢呋辛钠 有关物质 高效液相色谱 cefuroxime sodium related substance HPLC
  • 相关文献

参考文献3

  • 1The United States Pharmacopeial Convention.The United States Pharmacopeia[M].32nd ed.Baltimore:Port City Press,2009:1865-1866.
  • 2The British Pharmacopoeia Commission.The British Pharmacopoeia[M].London:the Stationary Office,2009:411-412.
  • 3Society of Japanese Association of Law Books.The Japanese Pharmacopoeia[M].15th ed.Tokyo:Society of Japanese Pharmacopoeia,2006:476.

同被引文献19

  • 1郭志渊,傅萍,谢华,张悦杨.茴拉西坦有关物质测定方法的改进[J].中国现代应用药学,2013,30(1):84-86. 被引量:3
  • 2He WW,Zhou XW,Lu JQ.Simultaneous determination of benserazide and levodopa by capillary electrophoresis-chemiluminescence using an improved interface[J].J Chromatogr A,2006,1131(1-2):289.
  • 3Zapata-Urzúa C,Pérez-Ortiz M,Bravo M, et al.Simultaneous voltammetric determination of levodopa,carbidopa and benserazide in pharmaceuticals using multivariate calibration[J].Talanta,2010,82(3):962.
  • 4Wang J,Zhou Y,Liang J, et al.Determination of levodopa and benserazide hydrochloride in pharmaceutical formulations by CZE with amperometric detection[J].Chromatographia,2005,61(5/6):265.
  • 5ChP 2010.Vol Ⅱ(中国药典2010年版.二部)[S].2010:704.
  • 6EP 7.0[S].2011:1459.
  • 7JP 16[S].2011:427.
  • 8Olivier C. Clinical use of cefuroxime in paediatric community-acquired pneumonia[J].Paediatr Drugs, 2000, 2(5):331-343.
  • 9张媛媛,刘均洪.多巴丝肼控释胶囊的制备及其质量控制[J].中国医院药学杂志,2010,30(10):838-841. 被引量:2
  • 10陈之敏,莫金娜,余锐玉,李汶.注射用头孢呋辛钠有关物质检查供试品溶液稳定性的研究[J].中国药品标准,2010,11(6):435-437. 被引量:2

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部